Patents by Inventor Kentarou ASAHI

Kentarou ASAHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkylene derivatives
    Patent number: 10150728
    Abstract: The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound. A compound of formula (I): wherein R1 is substituted or unsubstituted fused aromatic heterocyclyl etc., ring A is substituted or unsubstituted non-aromatic carbocycle etc., -L1- is —O—(CR6R7)m- etc., -L2- is —O—(CR6R7)n- etc., each R6 and R7 are independently hydrogen, halogen etc., R2 is substituted or unsubstituted alkyl, R3 is hydrogen or substituted or unsubstituted alkyl, R4 is substituted or unsubstituted alkylcarbonyl etc.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: December 11, 2018
    Assignee: SHIONOGI & CO., LTD.
    Inventors: Naotake Kobayashi, Kentarou Asahi, Yutaka Tomida, Masahide Ohdan, Masataka Fumoto, Yoshikazu Sasaki, Kana Kurahashi, Takatsugu Inoue, Tomomi Urabe, Yuji Nishiura, Masafumi Iwatsu, Keisuke Miyazaki, Naoki Ohyabu, Toshihiro Wada, Manabu Katou
  • LONG-ACTING HIV PROTEASE INHIBITOR
    Publication number: 20170253607
    Abstract: The present invention provides useful compounds for HIV protease inhibitor.
    Type: Application
    Filed: September 10, 2015
    Publication date: September 7, 2017
    Applicant: Shionogi & Co., Ltd.
    Inventors: Takashi KAWASUJI, Hidenori MIKAMIYAMA, Naoyuki SUZUKI, Koji MASUDA, Hideki SUGIMOTO, Azusa OKANO, Miho YOSHIDA, Shuichi SUGIYAMA, Kentarou ASAHI, Iori KOZONO, Keisuke MIYAZAKI, Hiroki OZASA, Masayoshi MIYAGAWA
  • NOVEL ALKYLENE DERIVATIVES
    Publication number: 20160257641
    Abstract: The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound. A compound of formula (I): wherein R1 is substituted or unsubstituted fused aromatic heterocyclyl etc., ring A is substituted or unsubstituted non-aromatic carbocycle etc., -L1- is —O—(CR6R7)m- etc., -L2- is —O—(CR6R7)n- etc., each R6 and R7 are independently hydrogen, halogen etc., R2 is substituted or unsubstituted alkyl, R3 is hydrogen or substituted or unsubstituted alkyl, R4 is substituted or unsubstituted alkylcarbonyl etc.
    Type: Application
    Filed: October 17, 2014
    Publication date: September 8, 2016
    Applicant: Shionogi & Co., Ltd.
    Inventors: Naotake KOBAYASHI, Kentarou ASAHI, Yutaka TOMIDA, Masahide OHDAN, Masataka FUMOTO, Yoshikazu SASAKI, Kana KURAHASHI, Takatsugu INOUE, Tomomi URABE, Yuji NISHIURA, Masafumi IWATSU, Keisuke MIYAZAKI, Naoki OHYABU, Toshihiro WADA, Manabu KATOU